P2‐039: PROGRESS OF THE PHASE I CLINICAL TRIAL TO EVALUATE LONGEVERON ALLOGENEIC MESENCHYMAL STEM CELLS (LMSCS) AS A POTENTIAL THERAPEUTIC FOR ALZHEIMER'S DISEASE.

Autor: Oliva, Anthony A., Baumel, Bernard, Brody, Mark, Agronin, Marc, Drouillard, Amy, Pena, Andrea, McClain-Moss, Lisa, Page, Suzanne L., Perez, Carmen, Landman, Jonathan, Alston, Tequesta, Bookheimer, Susan Y., Castaneda, Ricardo, Hare, Joshua M.
Zdroj: Alzheimer's & Dementia: The Journal of the Alzheimer's Association; Jul2019 7S Part 11, Vol. 15, pP586-P586, 1p
Databáze: Supplemental Index